On the Synergistic Effects of Ligand-Mediated and Phage-Intrinsic Properties During In Vivo Selection

Advances in Genetics - Tập 69 - Trang 115-133 - 2010
Wouter H.P. Driessen1, Lawrence F. Bronk1, Julianna K. Edwards1, Bettina Proneth1, Glauco R. Souza1, Paolo Decuzzi2,3, Renata Pasqualini1,4, Wadih Arap1,4
1David H. Koch Center, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA
2Department of Nanomedicine and Biomedical Engineering, The University of Texas Health Science Center at Houston, Houston, Texas, USA
3Center of Bio-/Nanotechnology and -/Engineering for Medicine, University of Magna Graecia, Catanzaro, Italy
4Department of Experimental Diagnostic Imaging, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA

Tài liệu tham khảo

Arap, 2002, Steps toward mapping the human vasculature by phage display, Nat. Med., 8, 121, 10.1038/nm0202-121 Barbas, 2001 Brown, 2004, Drug identification through in vivo screening of chemical libraries, Chembiochem, 5, 871, 10.1002/cbic.200300824 Caravan, 2007, Collagen-targeted MRI contrast agent for molecular imaging of fibrosis, Angew. Chem. Int. Ed. Engl., 46, 8171, 10.1002/anie.200700700 Cardo-Vila, 2010, From combinatorial peptide selection to drug prototype (II): Targeting the epidermal growth factor receptor pathway, Proc Natl Acad Sci USA, 107, 5118, 10.1073/pnas.0915146107 Christianson, 2007, Techniques to decipher molecular diversity by phage display, Methods Mol. Biol., 357, 385 De Mestre, 1975, Low-Reynolds-number translation of a slender cylinder near a plane wall, J. Eng. Math., 9, 81, 10.1007/BF01535390 Decuzzi, 2008, The receptor-mediated endocytosis of nonspherical particles, Biophys. J., 94, 3790, 10.1529/biophysj.107.120238 Decuzzi, 2005, A theoretical model for the margination of particles within blood vessels, Ann. Biomed. Eng., 33, 179, 10.1007/s10439-005-8976-5 Decuzzi, 2006, The effective dispersion of nanovectors within the tumor microvasculature, Ann. Biomed. Eng., 34, 633, 10.1007/s10439-005-9072-6 Decuzzi, 2009, Intravascular delivery of particulate systems: Does geometry really matter?, Pharm. Res., 26, 235, 10.1007/s11095-008-9697-x Dickson, 2004, Key factors in the rising cost of new drug discovery and development, Nat. Rev. Drug. Discov., 3, 417, 10.1038/nrd1382 Evans, 2007, Forces and bond dynamics in cell adhesion, Science, 316, 1148, 10.1126/science.1137592 Fang, 2003, Factors and mechanism of "EPR" effect and the enhanced antitumor effects of macromolecular drugs including SMANCS, Adv. Exp. Med. Biol., 519, 29, 10.1007/0-306-47932-X_2 Forgacs, 1959, Particle motions in sheared suspensions: IX. Spin and deformation of threadlike particles, J. Colloid Sci., 14, 457, 10.1016/0095-8522(59)90012-1 Forgacs, 1959, Particle motions in sheared suspensions: X. Orbits of flexible threadlike particles, J. Colloid Sci., 14, 473, 10.1016/0095-8522(59)90013-3 Geng, 2007, Shape effects of filaments versus spherical particles in flow and drug delivery, Nat. Nanotechnol., 2, 249, 10.1038/nnano.2007.70 Gestwicki, 2002, Influencing receptor-ligand binding mechanisms with multivalent ligand architecture, J. Am. Chem. Soc., 124, 14922, 10.1021/ja027184x Giordano, 2010, From combinatorial peptide selection to drug prototype (I): Targeting the vascular endothelial growth factor receptor pathway, Proc. Natl. Acad. Sci. USA, 107, 5112, 10.1073/pnas.0915141107 Goncalves, 2005, Binding of oligoarginine to membrane lipids and heparan sulfate: Structural and thermodynamic characterization of a cell-penetrating peptide, Biochemistry, 44, 2692, 10.1021/bi048046i Hajitou, 2006, Vascular targeting: Recent advances and therapeutic perspectives, Trends Cardiovasc. Med., 16, 80, 10.1016/j.tcm.2006.01.003 Helms, 2009, High-affinity peptide-based collagen targeting using synthetic phage mimics: From phage display to dendrimer display, J. Am. Chem. Soc., 131, 11683, 10.1021/ja902285m Hoffman, 2009, Tumor-targeting amino acid auxotrophic Salmonella typhimurium, Amino Acids, 37, 509, 10.1007/s00726-009-0261-8 Houghten, 2008, Strategies for the use of mixture-based synthetic combinatorial libraries: Scaffold ranking, direct testing in vivo, and enhanced deconvolution by computational methods, J. Comb. Chem., 10, 3, 10.1021/cc7001205 Iyer, 2006, Exploiting the enhanced permeability and retention effect for tumor targeting, Drug Discov. Today, 11, 812, 10.1016/j.drudis.2006.07.005 Johns, 2000, In vivo selection of sFv from phage display libraries, J. Immunol. Methods, 239, 137, 10.1016/S0022-1759(00)00152-6 Khalil, 2007, Single M13 bacteriophage tethering and stretching, Proc. Natl. Acad. Sci. USA, 104, 4892, 10.1073/pnas.0605727104 Kiessling, 2006, Synthetic multivalent ligands as probes of signal transduction, Angew. Chem. Int. Ed. Engl., 45, 2348, 10.1002/anie.200502794 Kolonin, 2006, Synchronous selection of homing peptides for multiple tissues by in vivo phage display, FASEB J., 20, 979, 10.1096/fj.05-5186fje Krag, 2006, Selection of tumor-binding ligands in cancer patients with phage display libraries, Cancer Res., 66, 7724, 10.1158/0008-5472.CAN-05-4441 Lesko, 2007, Paving the critical path: How can clinical pharmacology help achieve the vision?, Clin. Pharmacol. Ther., 81, 170, 10.1038/sj.clpt.6100045 Levitan, 1998, Stochastic modeling and optimization of phage display, J. Mol. Biol., 277, 893, 10.1006/jmbi.1997.1555 Li, 2002, Microtubule structure at 8 A resolution, Structure, 10, 1317, 10.1016/S0969-2126(02)00827-4 Maeda, 2001, The enhanced permeability and retention (EPR) effect in tumor vasculature: The key role of tumor-selective macromolecular drug targeting, Adv. Enzyme Regul., 41, 189, 10.1016/S0065-2571(00)00013-3 Maeda, 2001, SMANCS and polymer-conjugated macromolecular drugs: Advantages in cancer chemotherapy, Adv. Drug Deliv. Rev., 46, 169, 10.1016/S0169-409X(00)00134-4 Maeda, 2009, Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effect, Eur. J. Pharm. Biopharm., 71, 409, 10.1016/j.ejpb.2008.11.010 Mammen, 1998, Polyvalent interactions in biological systems: Implications for design and use of multivalent ligands and inhibitors, Angew. Chem. Int. Ed. Engl., 37, 2754, 10.1002/(SICI)1521-3773(19981102)37:20<2754::AID-ANIE2754>3.0.CO;2-3 Matsumura, 1986, A new concept for macromolecular therapeutics in cancer chemotherapy: Mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs, Cancer Res., 46, 6387 Merkel, 1999, Energy landscapes of receptor-ligand bonds explored with dynamic force spectroscopy, Nature, 397, 50, 10.1038/16219 Molenaar, 2002, Uptake and processing of modified bacteriophage M13 in mice: Implications for phage display, Virology, 293, 182, 10.1006/viro.2001.1254 Nakashima, 1975, Primary structure and sidechain interactions of PFL filamentous bacterial virus coat protein, Nature, 253, 68, 10.1038/253068a0 Ozawa, 2008, Beyond receptor expression levels: The relevance of target accessibility in ligand-directed pharmacodelivery systems, Trends Cardiovasc. Med., 18, 126, 10.1016/j.tcm.2008.03.001 Park, 2002, Anti-HER2 immunoliposomes: Enhanced efficacy attributable to targeted delivery, Clin. Cancer Res., 8, 1172 Park, 2009, Systematic surface engineering of magnetic nanoworms for in vivo tumor targeting, Small, 5, 694, 10.1002/smll.200801789 Pasqualini, 1996, Organ targeting in vivo using phage display peptide libraries, Nature, 380, 364, 10.1038/380364a0 Pasqualini, 2010, Leveraging molecular heterogeneity of the vascular endothelium for targeted drug delivery and imaging, Semin. Thromb. Hemost., 36, 343, 10.1055/s-0030-1253456 Qian, 2010, Macrophage diversity enhances tumor progression and metastasis, Cell, 141, 39, 10.1016/j.cell.2010.03.014 Smith, 1997, Phage display, Chem. Rev., 97, 391, 10.1021/cr960065d Stover, 1990, The motion of rodlike particles in the pressure-driven flow between two flat plates, Rheol. Acta, 29, 192, 10.1007/BF01331355 Tasciotti, 2008, Mesoporous silicon particles as a multistage delivery system for imaging and therapeutic applications, Nat. Nanotechnol., 3, 151, 10.1038/nnano.2008.34 Tornberg, 2004, Simulating the dynamics and interactions of flexible fibers in stokes flows, J. Comput. Phys., 196, 8, 10.1016/j.jcp.2003.10.017 Trepel, 2008, Chapter 4: Screening phage-display peptide libraries for vascular targeted peptides, Methods Enzymol., 445, 83, 10.1016/S0076-6879(08)03004-8 Wang, 2006, The structure of a filamentous bacteriophage, J. Mol. Biol., 361, 209, 10.1016/j.jmb.2006.06.027 Wiseman, 1976, Different arrangements of protein subunits and single-stranded circular DNA in the filamentous bacterial viruses fd and Pf1, J. Mol. Biol., 102, 549, 10.1016/0022-2836(76)90333-8 Woodcock, 2008, The FDA critical path initiative and its influence on new drug development, Annu. Rev. Med., 59, 1, 10.1146/annurev.med.59.090506.155819 Woolley, 2001, Deposition and characterization of extended SIngle-stranded DNA molecules on surfaces, Nano Lett., 1, 345, 10.1021/nl0155476 Zhang, 2002, Force spectroscopy of the leukocyte function-associated antigen-1/intercellular adhesion molecule-1 interaction, Biophys. J., 83, 2270, 10.1016/S0006-3495(02)73987-8 Zhao, 2005, Tumor-targeting bacterial therapy with amino acid auxotrophs of GFP-expressing Salmonella typhimurium, Proc. Natl. Acad. Sci. USA, 102, 755, 10.1073/pnas.0408422102 Zhao, 2006, Targeted therapy with a Salmonella typhimurium leucine-arginine auxotroph cures orthotopic human breast tumors in nude mice, Cancer Res., 66, 7647, 10.1158/0008-5472.CAN-06-0716 Ziegler, 2003, Protein transduction domains of HIV-1 and SIV TAT interact with charged lipid vesicles. Binding mechanism and thermodynamic analysis, Biochemistry, 42, 9185, 10.1021/bi0346805 Zimmermann, 1986, The ionic properties of the filamentous bacteriophages Pf1 and fd, J. Biol. Chem., 261, 1653, 10.1016/S0021-9258(17)35990-2 Zou, 2004, Biodistribution of filamentous phage peptide libraries in mice, Mol. Biol. Rep., 31, 121, 10.1023/B:MOLE.0000031459.14448.af